<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04914039</url>
  </required_header>
  <id_info>
    <org_study_id>2020-031</org_study_id>
    <nct_id>NCT04914039</nct_id>
  </id_info>
  <brief_title>Evaluation of CTA on the Assessment of Brain Death</brief_title>
  <official_title>Evaluation of CTA on the Assessment of Brain Death</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, different countries have different standards for the diagnosis of brain death,&#xD;
      but according to the classic brain death confirmation test, it needs to be combined with&#xD;
      transcranial Doppler, EEG, evoked potential and apnea test in clinical practice. Some&#xD;
      patients cannot undergo a complete clinical examination and apnea test due to certain&#xD;
      factors, and the determination of brain death is limited. The American Academy of Neurology&#xD;
      (AAN) guidelines regard cerebral angiography as an acceptable auxiliary examination and is&#xD;
      widely regarded as the gold standard for cerebral blood flow evaluation. CT cerebrovascular&#xD;
      angiography (CTA) is a noninvasive and widely used examination method that can identify&#xD;
      missing or severely reduced cerebral blood flow. However, due to limited experience and lack&#xD;
      of sufficient evidence to prove its reliability, it is not included in the AAN A recognized&#xD;
      auxiliary examination; there are also a large number of domestic and foreign literature&#xD;
      reports that CTA can be used as a new confirmation test for clinical judgment of brain death.&#xD;
&#xD;
      This study aims to explore the value of CTA in the judgment of patients with brain death.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>CTA used as an auxiliary diagnosis to determine brain death</measure>
    <time_frame>through study completion, an average of 3 years.</time_frame>
    <description>CTA used as an auxiliary diagnosis to determine brain death</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Brain Death</condition>
  <arm_group>
    <arm_group_label>CTA examination</arm_group_label>
    <description>CTA examination group for suspected brain death</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Confirmed</arm_group_label>
    <description>Confirmed group for brain death</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Combination Product</intervention_name>
    <description>Cases of brain death confirmed by the classic brain death confirmation test</description>
    <arm_group_label>CTA examination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NO CTA examination</intervention_name>
    <description>NO CTA examination</description>
    <arm_group_label>Confirmed</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        CTA imaging data of 63 patients with clinically suspected brain death&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recruiting, no definite&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Recruiting, no definite&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brain Center, Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peng XU</last_name>
      <phone>+86 18758276628</phone>
      <email>xupeng@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>brain death</keyword>
  <keyword>CT angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Death</mesh_term>
    <mesh_term>Death</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

